Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Jensterle M, Kocjan T, Kravos NA, Pfeifer M, Janez A
Jia Y, Yang H, Yu J, Li Z, Jia G, Ding B, Lv C (2023) Crocin suppresses breast cancer cell proliferation by down-regulating tumor promoter miR-122-5p and up-regulating tumor suppressors FOXP2 and SPRY2
Noom Weight: $17.42/month (12-month plan, $209 upfront)
Bioma Probiotics enters this trend as a case study in how brands can participate in these evolving conversations without making product claims
The Numbers: Injectable tirzepatide: Nearly 100% bioavailability (all medication reaches bloodstream) Oral peptides without enhancement: Less than 1% bioavailability This means youd need 100 times more medication in oral form to match injection effectiveness Technical Barriers: Creating an oral version requires solving multiple problems: Protecting the peptide from stomach acid Preventing breakdown by digestive enzymes Getting the large molecule through intestinal walls Maintaining therapeutic drug levels Doing all this at a reasonable cost Current Development Status: Eli Lilly has not publicly announced advanced clinical trials for oral tirzepatide
US$ 26.69
US$ 22.23
US$ 26.86
US$ 23.35
US$ 24.77
US$ 22.36
